Evidence map›Paper›PMID 32049634›Full record

Trial reportBMJ open diabetes research & care2020

Low-energy total diet replacement intervention in patients with type 2 diabetes mellitus and obesity treated with insulin: a randomized trial.

Adrian Brown, Anne Dornhorst, Barbara McGowan, Omar Omar, Anthony R Leeds, Shahrad Taheri, Gary S Frost

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ open diabetes research & care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 5 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 5 syntheses or guidelines pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. COVID-19: Obesity, deprivation and death.Journal of global health · 2020
    Review
  19. Diet and exercise in the prevention and treatment of type 2 diabetes mellitus.Nature reviews. Endocrinology · 2020 · on this map
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 4 countries.

Adrian BrownNutrition and Dietetic Research Group, Imperial College London, London, UK.
Anne DornhorstDivision of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK.
Barbara McGowanInstitute of Diabetes, Endocrinology and Obesity, Guy's and St Thomas' Hospital, London, UK.
Omar OmarDepartment of Medicine and Clinical Research Core, Weill Cornell Medicine-Qatar, Qatar-Foundation Education City, Doha, Qatar.
Anthony R LeedsNutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
Shahrad TaheriDivision of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK.
Gary S FrostNutrition and Dietetic Research Group, Imperial College London, London, UK g.frost@imperial.ac.uk.ORCID 0000-0003-0529-6325
Imperial College London · GBCancer Research UK Clinical Trials Unit · GBCornell University · USSt Thomas' Hospital · GBUniversity College London · GBUniversity of Copenhagen · DK

Funding

Biotechnology and Biological Sciences Research CouncilMedical Research Council
6 · The paper itself

Abstract

objectivesThe management of patients with long-standing type 2 diabetes and obesity receiving insulin therapy (IT) is a substantial clinical challenge. Our objective was to examine the effect of a low-energy total diet replacement (TDR) intervention versus standardized dietetic care in patients with long-standing type 2 diabetes and obesity receiving IT. RESEARCH DESIGN AND

methodsIn a prospective randomized controlled trial, 90 participants with type 2 diabetes and obesity receiving IT were assigned to either a low-energy TDR (intervention) or standardized dietetic care (control) in an outpatient setting. The primary outcome was weight loss at 12 months with secondary outcomes including glycemic control, insulin burden and quality of life (QoL).

resultsMean weight loss at 12 months was 9.8 kg (SD 4.9) in the intervention and 5.6 kg (SD 6.1) in the control group (adjusted mean difference -4.3 kg, 95% CI -6.3 to 2.3, p<0.001). IT was discontinued in 39.4% of the intervention group compared with 5.6% of the control group among completers. Insulin requirements fell by 47.3 units (SD 36.4) in the intervention compared with 33.3 units (SD 52.9) in the control (-18.6 units, 95% CI -29.2 to -7.9, p=0.001). Glycated Hemoglobin (HbA1c) fell significantly in the intervention group (4.7 mmol/mol; p=0.02). QoL improved in the intervention group of 11.1 points (SD 21.8) compared with 0.71 points (SD 19.4) in the control (8.6 points, 95% CI 2.0 to 15.2, p=0.01).

conclusionsPatients with advanced type 2 diabetes and obesity receiving IT achieved greater weight loss using a TDR intervention while also reducing or stopping IT and improving glycemic control and QoL. The TDR approach is a safe treatment option in this challenging patient group but requires maintenance support for long-term success. TRIAL REGISTRATION NUMBER: ISRCTN21335883.

Indexed as

Diabetes Mellitus, Type 2Quality of LifeDietHumansInsulinObesityProspective StudiesInsulininsulinlow calorie dietobesitytype 2 diabetes

Identifiers

PMID32049634
PMCPMC7039597
OpenAlexW3003453642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.